www.fdanews.com/articles/113498-abbott-completes-acquisition-of-ibis-biosciences

Abbott Completes Acquisition of Ibis Biosciences

January 6, 2009

Isis Pharmaceuticals, Inc. and Abbott announced that Abbott has completed its purchase of Ibis Biosciences, Inc., an Isis subsidiary, for a closing purchase price of $175 million.
SunHerald.com